// App-Quantinova.ai

37 OC3.4 : Cardiovascular risk factors in patients with medically observed and operated primary hyperparathyroidism

Researchers

Presenter

  • Berna Imge Aydogan

Principal Investigators

  • Asena Gokcay Canpolat

  • Cansin Tulunay Kaya

  • Mustafa Sahin

  • Demet Corapcioglu

  • Ali Riza Uysal

  • Rifat Emral

Medical Centers

  • Department of Endocrinology and Metabolism, Medical Faculty, Ankara University, Ankara, Turkey

  • Department of Public Health, Faculty of Medicine, Pamukkale University, Denizli, Turkey

  • Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Primary hyperparathyroidism

  • Vasodilation dysfunction

Biomarkers

  • High sensitivity C-reactive protein

  • Interleukin-8

  • Soluble CD40-ligand

Drug/Treatment

  • Ergocalciferol

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved